#Engitix
LightNews LightNews
amsocmatbio.bsky.social
Two of medicine's hardest problems: fibrosis & cancer. #ECMatrix is at the center.
Giuseppe Mazza, CEO of Engitix and an honorary Professor at @ucl.ac.uk, is pioneering ECM-driven drug discovery to tackle them.
Hear from him in our #ASMB2025 Biotech & Pharma series
📽️👇
youtu.be/3xzpHfpV9Ac
Giuseppe Mazza, CEO of Engitix
YouTube video by ASMB - American Society for Matrix Biology
youtu.be
April 9, 2026 at 9:40 PM
nextflow.io
Senior Bioinformatician at Engitix Therapeutics, a biotech company leveraging extracellular matrix research to develop new therapies.

www.newscientist.com/nsj/job/1402...
Senior Bioinformatician - London, United Kingdom job with Engitix Therapeutics | 1402139731
Your mission We are seeking a senior bioinformatician to join the Data Sciences team and work closely with both internal and external collaborators
www.newscientist.com
March 25, 2025 at 12:49 PM
nextflow.io
👉Principal Bioinformatician at Engitix Therapeutics, a biotech company using extracellular matrix research to develop new treatments for fibrosis and cancer.

www.newscientist.com/nsj/job/1402...
February 12, 2025 at 9:10 AM
amsocmatbio.bsky.social
Our next #SneakPeek 👀 just dropped!!
Join us as we sit down with #ECMatrix leaders shaping what's next in biotech & pharma.
Featuring Nordic Bioscience, PharmaNest Inc, Engitix & Nippi Institute of Biomatrix.
🎥Full #ASMB2025 interviews drop all week.
Follow along👇
youtube.com/shorts/rI5bK...
Biotech and Pharma leaders
YouTube video by ASMB - American Society for Matrix Biology
youtube.com
April 6, 2026 at 9:52 PM
francais.awp.news
Lonza signe un accord de licence avec le britannique Engitix

https://www.awp.ch/sharedarticles?articleid=-1974799416
July 21, 2026 at 12:57 PM
healthcaretoday.bsky.social
Engitix Therapeutics, a biotech company targeting the extracellular matrix to develop therapies for cancer and fibrosis, has closed $25 million (£18.6 million) Series A extension financing by Netherton Investments.

healthcaretoday.com/article/engi...

#Healthcare #Biotech #CancerTherapy #Investment
January 23, 2026 at 9:31 AM
4040rec.bsky.social
#biotech #GSK #Nuvalent #MandA #GSK #Nuvalent #Oncology #lungcancer #antibodydrugconjugate #ADC #ALKinhibitor #NSCLC #ROS1positiveNSCLC #ALKpositiveNSCLC #RAPTTherapeutics #Liverfibrosis #Engitix #liverfibrosis #Hepatology #BostonTherapeutics #SLD #chronichepatitisBtherapy
zurl.co/6i8wS
GSK pursues $10.6bn takeover of cancer biotech Nuvalent
GSK is preparing for its biggest acquisition in more than 10 years, agreeing to buy cancer drug developer Nuvalent for $10.6 billion.
zurl.co
June 10, 2026 at 11:54 AM
beinsure.com
London-based Engitix secures a €21mn Series A extension to advance ECM-targeted oncology and fibrosis drug programs beinsure.com/news/biotech...
BioTech Engitix lands €21 mn extension to push ECM cancer therapies
London-based Engitix secures a €21mn Series A extension to advance ECM-targeted oncology and fibrosis drug programs
beinsure.com
January 9, 2026 at 10:31 PM
danvzla.bsky.social
longevity.technology/news/can-liv...
Can liver fibrosis be undone? Engitix, GSK aim to find out
New collaboration shifts the focus from slowing liver damage to understanding how scarred tissue may heal itself.
longevity.technology
June 11, 2026 at 12:14 PM
johnhuww.bsky.social
GSK signs £45m deal with UCL offshoot for liver fibrosis drugs

“For GSK, based in London’s Knowledge Quarter, it deepens its partnerships with biotechs and universities in Britain’s so-called “golden triangle” and its growing specialism in hepatology”

www.thetimes.com/article/cff4...
GSK signs £45m deal with UCL offshoot for liver fibrosis drugs
The pharmaceuticals giant and White City-based Engitix have struck an agreement focused on drugs aimed at reversing the condition
www.thetimes.com
June 9, 2026 at 6:07 AM
nextflow.io
Senior Bioinformatician at Engitix Therapeutics , a biotech company pioneering extracellular matrix-targeting treatments for fibrosis and cancer. www.newscientist.com/nsj/job/1402...
Senior Bioinformatician - London, United Kingdom job with Engitix Therapeutics | 1402164909
Your mission We are seeking a senior bioinformatician to join the Data Sciences team and work closely with both internal and external collaborators
www.newscientist.com
April 30, 2025 at 3:43 PM
longevitytech.bsky.social
https://longevity.technology/news/can-liver-fibrosis-be-undone-engitix-gsk-aim-to-find-out/
June 11, 2026 at 8:23 AM
longevitytech.bsky.social
New collaboration shifts the focus from slowing liver damage to understanding how scarred tissue may heal itself.

Link as first comment.

#longevity #liverfibrosis #fibrosis #biotech #regenerativemedicine
A scientist wearing a lab coat and green gloves conducts research in a lab with Engitix branding. The mood is focused and professional.
June 11, 2026 at 8:23 AM
longevitytech.bsky.social
Engitix is betting that fixing the body’s damaged tissue environment could unlock better cancer care and a longer healthspan.

longevity.technology/news/engitix...

#longevity #agingbiology #tissuetech #ECM #healthspan #biotech #fibrosis #innovation
January 8, 2026 at 8:17 PM